Rough Draft Atlanta on MSN2d
Researchers expect FDA to approve a twice-yearly shot that reduces risk of HIV infection by 96%Roughly 61,000 Georgians live with HIV, the sexually transmitted virus (STI) that can lead to AIDS, and Atlanta ranks in the ...
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...
WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable ...
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...
Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...
Lenacapavir for Alzheimer’s, an orca attacking a shark, and a moon landing are set to mark key scientific and technological ...
Uganda is registering around 38,000 new infections despite the deployment of different interventions such as condoms and oral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback